Up to 7% of Adults Have Undiagnosed Thyroid Dysfunction

Thyroid dysfunction is one of the most common endocrine disorders in the world, and a significant proportion of cases remain undiagnosed. A retrospective study published in the Journal of the Endocrine Society combined NHANES survey data with claims records from 2009 to 2019 and confirmed what earlier large-scale studies had suggested: approximately 4 to 7% of community-derived populations in the United States and Europe have biochemical evidence of hypothyroidism that has never been clinically identified.

The NHANES III data found that 4.6% of the US population had undiagnosed hypothyroidism, with 0.3% meeting criteria for overt clinical disease and 4.3% classified as subclinical. Subclinical hypothyroidism, where TSH is elevated but thyroid hormones remain in the normal range, accounts for roughly four out of five undiagnosed cases. While subclinical disease is often dismissed as clinically insignificant, it can produce fatigue, weight gain, cognitive sluggishness, and mood changes that significantly impair quality of life and are frequently misattributed to aging, stress, or depression.

The demographics of undiagnosed thyroid dysfunction follow predictable patterns. Prevalence is higher in women than men, in older adults compared to younger populations, and in certain ethnic groups. These disparities persist even after adjusting for access to care, suggesting that screening practices and clinical awareness, not just insurance coverage, drive the diagnostic gap.

Thyroid dysfunction also interacts with other hormonal systems. Hypothyroidism elevates SHBG, alters cortisol metabolism, and can suppress reproductive hormones, meaning that an undiagnosed thyroid problem can make other hormonal abnormalities appear worse than they actually are.

The Tracking Connection

Kairos™ includes thyroid markers, particularly TSH, as part of its core hormonal panel tracking because thyroid dysfunction is both common and commonly missed. By trending TSH alongside energy, weight, mood, and other hormonal levels over time, Kairos helps users identify the slow-onset pattern of subclinical hypothyroidism before it progresses to overt disease or confounds the interpretation of other lab results.